NexGel (NXGL) Competitors $2.47 -0.06 (-2.37%) Closing price 04:00 PM EasternExtended Trading$2.48 +0.01 (+0.61%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. VANI, ICCM, QTI, LUNG, TELA, SURG, CTSO, DXR, MDAI, and PYPDShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Vivani Medical (VANI), IceCure Medical (ICCM), QT Imaging (QTI), Pulmonx (LUNG), TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Daxor (DXR), Spectral AI (MDAI), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Vivani Medical IceCure Medical QT Imaging Pulmonx TELA Bio SurgePays Cytosorbents Daxor Spectral AI PolyPid Vivani Medical (NASDAQ:VANI) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment. Is VANI or NXGL more profitable? Vivani Medical has a net margin of 0.00% compared to NexGel's net margin of -25.02%. NexGel's return on equity of -49.37% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -194.66% -68.64% NexGel -25.02%-49.37%-25.68% Do insiders and institutionals have more ownership in VANI or NXGL? 6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 46.4% of Vivani Medical shares are held by insiders. Comparatively, 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, VANI or NXGL? Vivani Medical has a beta of 3.12, meaning that its stock price is 212% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Do analysts recommend VANI or NXGL? Vivani Medical currently has a consensus price target of $4.00, suggesting a potential upside of 166.67%. Given Vivani Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vivani Medical is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, VANI or NXGL? NexGel has higher revenue and earnings than Vivani Medical. NexGel is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$23.49M-$0.45-3.33NexGel$8.69M2.29-$3.28M-$0.40-6.18 Does the media prefer VANI or NXGL? In the previous week, Vivani Medical had 6 more articles in the media than NexGel. MarketBeat recorded 6 mentions for Vivani Medical and 0 mentions for NexGel. Vivani Medical's average media sentiment score of 1.12 beat NexGel's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media. Company Overall Sentiment Vivani Medical Positive NexGel Neutral SummaryVivani Medical beats NexGel on 10 of the 15 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.93M$6.68B$5.74B$10.43BDividend YieldN/A1.21%5.61%4.58%P/E Ratio-6.1725.7976.4926.64Price / Sales2.29195.34551.27126.90Price / CashN/A22.1425.8131.15Price / Book2.745.0513.626.47Net Income-$3.28M$178.07M$3.29B$271.57M7 Day Performance0.82%1.96%1.67%2.86%1 Month Performance6.47%6.88%4.03%7.26%1 Year Performance-3.89%20.82%80.59%26.02% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGelN/A$2.47-2.4%N/A-7.7%$19.93M$8.69M-6.1710Positive NewsVANIVivani Medical3.419 of 5 stars$1.21-4.7%$4.00+230.6%+26.0%$71.68MN/A-2.6920Positive NewsICCMIceCure Medical2.4328 of 5 stars$1.02-5.6%$2.39+133.8%+67.2%$70.07M$3.29M-6.3860QTIQT ImagingN/A$2.48-2.7%N/A+279.9%$67.29M$4.00M0.00N/AGap DownLUNGPulmonx3.3936 of 5 stars$1.58-0.6%$7.66+385.1%-78.6%$64.38M$90.55M-1.10250TELATELA Bio2.0024 of 5 stars$1.58flat$4.50+184.8%-37.8%$62.59M$75.32M-1.41120SURGSurgePays2.9372 of 5 stars$2.99-2.0%$9.00+201.0%+81.1%$61.09M$60.88M-1.2040CTSOCytosorbents2.0284 of 5 stars$0.91-0.7%$5.50+505.0%-37.7%$57.06M$35.60M-5.35220DXRDaxor4.0409 of 5 stars$11.43-1.8%$25.00+118.7%+25.8%$55.29M$3.31M0.0037News CoveragePositive NewsMDAISpectral AI2.9572 of 5 stars$2.06+3.5%$3.50+69.9%+123.8%$55.07M$27.55M-2.9983Gap UpPYPDPolyPid3.2722 of 5 stars$3.43+1.2%$12.40+261.5%+2.6%$54.53MN/A-0.9080Positive News Related Companies and Tools Related Companies VANI Alternatives ICCM Alternatives QTI Alternatives LUNG Alternatives TELA Alternatives SURG Alternatives CTSO Alternatives DXR Alternatives MDAI Alternatives PYPD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXGL Stock Alerts